Zydus Lifesciences locked in 5% upper circuit of Rs 1,140.45 after the pharma major reported consolidated net profit of Rs 1,182.3 crore in Q4 FY24 steeply higher than Rs 296.6 crore recorded in Q4 FY23.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
